newsfilter
← Latest News
PR Newswire·

Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences

Viracta Therapeutics, Inc. (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today announced that the...